Clinical Trial Update: A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery [Phase 3]

View source ↗

Summary

A Phase 3 study comparing a new eye drop formulation to REFRESH PLUS® in participants after LASIK refractive surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bilateral Lasik Surgery

Drugs mentioned

• New Eye Drop Formulation
• Refresh Plus

Snippet

Sponsor: Allergan | Conditions: Bilateral LASIK Surgery | Phase 3 | Status: COMPLETED | Results posted: 2015-10-05